Correction to: Neratinib in Early-Stage Breast Cancer: A Profile of Its Use in the EU
Crossref DOI link: https://doi.org/10.1007/s40261-019-00758-9
Published Online: 2019-02-06
Published Print: 2019-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dhillon, Sohita
Text and Data Mining valid from 2019-02-01
Article History
First Online: 6 February 2019